Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.50p
   
  • Change Today:
      0.35p
  • 52 Week High: 17.60
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 502.22m
  • Volume: 6,078,976
  • Market Cap: £62.78m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £186,058
Lisa Baderoon 583,963 £72,995
Tim Franklin 525,000 £65,625

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £5,618,244
Luca & Associates AG 22,000,000 £2,750,000
Invesco Ltd 17,872,341 £2,234,043
Aviva Investors Global 11,285,180 £1,410,648
Alora Pharmaceuticals LLC 10,909,091 £1,363,636
M&G Investments 7,600,000 £950,000
Prudential plc 7,600,000 £950,000
Capital Income Builder 4,870,367 £608,796
Dr R Zimmer 4,551,553 £568,944
Odey Asset Management 3,433,319 £429,165
Rhone Trustees (Switzerland) SA 3,386,000 £423,250
Pictet Overseas Trust Corporation Limited 3,287,500 £410,938

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 12.50p
Change Today 0.35p
% Change 2.88 %
52 Week High 17.60
52 Week Low 1.09
Volume 6,078,976
Shares Issued 502.22m
Market Cap £62.78m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 19-Sep-2025

Time Volume / Share Price
16:29 75,000 @ 11.95p
16:12 60,000 @ 11.95p
15:09 150,000 @ 11.69p
16:00 81,967 @ 12.20p
15:47 100,000 @ 12.20p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page